Awesome new interview on the decades-long quest to understand neurobiological + genetic risk factors for severe mental illness, with Prof Carrie Bearden, shared by @mjalbrzikowski.bsky.social genomicpress.kglmeridian.com/view/journal...
Mo Sendi
@mosendi.bsky.social
Ph.D. in BME and ECE, Assistant Neuroscientist at McLean Hospital, and Instructor in Psychiatry at Harvard Medical School. Specializes in neuroimaging, neuromodulation, and genetics, focusing on anxiety, PTSD, and depression. Husband and father of one..
I hope you will all join me in expressing your thanks to the NIH and NSF staff who are working in an impossibly difficult and chaotic environment to keep science going in our country.
Now accepted at Nature Computational Science: Nicole shows how #Bayesian #hierarchical #models can explicitly model major #source of #population #stratification in 10,000 ABCD subjects. pmc.ncbi.nlm.nih.gov/articles/PMC...
Looking for a #postdoc in a multimodal #neuropsych lab studying novel #PTSD interventions & #stress biomarkers? My lab @emoryuniversity.bsky.social is hiring! Supported by #NIMH, #NCCIH #R01s. My team is creative, passionate, & delightfully quirky--join us. faculty-emory.icims.com/jobs/141032/...
Careers | Emory University | Atlanta GA
faculty-emory.icims.com
🥂 IT'S A WRAP !!! 💡ENIGMA's 2024 End-of-Year VIDEO ( youtube.com/watch?v=lJ9E... ) highlights discoveries by 2,000+ scientists from 45 countries, investigating 30+ brain diseases through brain mapping, genomics, environmental studies, treatments, neurostimulation, prevention across cultures (1/n)..
Please visit your local library and get a card. Even if you don’t use it right now you may in the future. Keep our libraries open.
TMS is cost-effective for treatment resistant depression relative to the next pharmacological treatment step. doi.org/10.1111/acps... Congrats Iris Dalhuisen and colleagues.
Cost‐Effectiveness of rTMS as a Next Step in Antidepressant Non‐Responders: A Randomized Comparison With Current Antidepressant Treatment Approaches
Background Although repetitive transcranial magnetic stimulation (rTMS) is an effective and commonly used treatment option for treatment-resistant depression, its cost-effectiveness remains much les...
doi.org
Thrilled to share our novel framework combining machine learning with SHAP for explainable FNC analysis! @mosendi.bsky.social @vcalhoun.bsky.social @trendscenter.bsky.social Preprint: www.biorxiv.org/content/10.1...
Congratulations to the new 2025 Associate Members, Members, and Fellows! #ACNP2024 New Associate Member List: bit.ly/3PqDeAJ New Members List: bit.ly/3BuqDsS New Fellows List: bit.ly/3DtohLu
Honored that a piece I wrote made it to NYTimes. It’s about how my mom’s stroke changed my connection to time, science, and nature. What a privilege to honor my mom in Modern Love. Below is a gift link. Let me know your thoughts 🙏🏼 www.nytimes.com/2024/12/20/s...
Grief Makes Us Time Travelers (Gift Article)
A neuroscientist studying memory, I used to believe time was linear. Then my mother had a stroke.
nytimes.com
Excited to share our novel white matter ICN template and preprint from 100K+ fMRI scans, revealing 97 ICNs and novel WM-GM insights. Preprint: biorxiv.org/content/10.1... @vcalhoun.bsky.social
New blogpost of our OHBM 2024 award winner series! Dr. Vince Calhoun (@vcalhoun.bsky.social), winner of the 2024 Glass brain award winner reflects on his career, recent developments in neuroscience, and more. Read it here: bit.ly/4iFd8qJ
Interview with Prof. Vince Calhoun, 2024 Winner of the Glass Brain award — OHBM Communications
Author: Ashley Tyrer Editor: Audrey Luo, Elisa Guma, Kevin Sitek , Megan Sheppard, Simon R. Steinkamp
bit.ly
Association of polygenic scores for neuropsychiatric traits with self-reported professions based on analysis of 420k individuals from UK Biobank and Million Veteran Program. Look at the 'arts & design' category. Artistic talent comes at a cost--a piece of your mind :)
